{
  "id": 19495638,
  "title": "Taking Ozempic or Wegovy? New eye warning raises questions in UAE",
  "url": "https://urgent.news/2026/11/11/taking-ozempic-or-wegovy-new-eye-warning-raises-questions-in-uae",
  "topic": "world",
  "section": "World",
  "published": "2026-11-11T12:20:11.000Z",
  "source": {
    "name": "Gulf News",
    "slug": "gulf-news",
    "url": "https://gulfnews.com/business/markets/taking-ozempic-or-wegovy-new-eye-warning-raises-questions-in-uae-1.500743835"
  },
  "original_language": "en",
  "account": null,
  "summary": "Dubai: A new US warning about a rare eye condition associated with popular diabetes and weight-loss medicines has raised fresh questions for UAE patients, as recent local research highlights gaps in medicine counselling and the need for more evidence on long-term safety. The US Food and Drug Administration (FDA) has ordered updated safety warnings for GLP-1 medicines, including Novo Nordisk's…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}